Yorktown Management & Research Company’s Allergan plc AGN Stock Holding History

Yorktown Management & Research Company’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,000	Closed	-$293K	–	364
2019 Q1	$293K	Hold	2,000	–	–	0.09%	254
2018 Q4	$267K	Hold	2,000	–	–	0.09%	257
2018 Q3	$381K	Buy	+2,000	New	+$367K	0.11%	195
2017 Q4	–	Sell	-1,100	Closed	-$225K	–	431
2017 Q3	$225K	Hold	1,100	–	–	0.06%	349
2017 Q2	$267K	Hold	1,100	–	–	0.09%	199
2017 Q1	$263K	Hold	1,100	–	–	0.07%	231
2016 Q4	$231K	Hold	1,100	–	–	0.06%	301
2016 Q3	$253K	Hold	1,100	–	–	0.06%	208
2016 Q2	$254K	Hold	1,100	–	–	0.06%	219
2016 Q1	$295K	Hold	1,100	–	–	0.06%	220
2015 Q4	$344K	Hold	1,100	–	–	0.06%	206
2015 Q3	$299K	Sell	1,100 -532	-33%	-$163K	0.05%	242
2015 Q2	$495K	Sell	1,632 -157	-9%	-$46.8K	0.09%	156
2015 Q1	$532K	Buy	1,789 +589	+49%	+$168K	0.1%	144
2014 Q4	$309K	Hold	1,200	–	–	0.06%	152
2014 Q3	$290K	Hold	1,200	–	–	0.06%	182
2014 Q2	$268K	Hold	1,200	–	–	0.05%	272
2014 Q1	$247K	Buy	+1,200	New	+$238K	0.05%	322

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Yorktown Management & Research Company's AGN Position: Q2 2019 in Review

Yorktown Management & Research Company sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 2,000 shares — an estimated $293K sold.

Yorktown Management & Research Company first reported a position in AGN in Q1 2014 and held it in 18 quarters. The position peaked at $532K in Q1 2015. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

Yorktown Management & Research Company reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
Yorktown Management & Research Company sold 2,000 Allergan plc shares in Q2 2019, an estimated $293K.
Yorktown Management & Research Company first reported a position in Allergan plc in Q1 2014 and held it in 18 quarters.
Yorktown Management & Research Company's Allergan plc position peaked at $532K in Q1 2015.
971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Yorktown Management & Research Company's 13F filing for Q2 2019, filed 2 Aug 2019.